Boehringer Ingelheim

Which big pharma firms are best at digital?
Which big pharma firms are best at digital?
Pharmaforum
digital pharma
Bayer
Pfizer
Boehringer Ingelheim
Flag link:
Boehringer's VC wing backs anti-cancer virus startup
Boehringer's VC wing backs anti-cancer virus startup
Fierce Biotech
Abalos Therapeutics
arenavirus
Boehringer Ingelheim
cancer
Flag link:
As developers work on cracking KRAS, Germany's Boehringer has quietly begun testing its pan-KRAS drug in humans
As developers work on cracking KRAS, Germany's Boehringer has quietly begun testing its pan-KRAS drug in humans
Endpoints
KRAS
cancer
Boehringer Ingelheim
Flag link:
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Fierce Pharma
Boehringer Ingelheim
Ofev
idiopathic pulmonary fibrosis
Flag link:
Boehringer Ingelheim signs retinal disease deal with Inflammasome
Boehringer Ingelheim signs retinal disease deal with Inflammasome
Pharmaceutical Business Review
Boehringer Ingelheim
Inflammasome Therapeutics
retinal disease
Flag link:
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
kidney disease
JNJ
EASD
Flag link:
ICER dings Novo's new oral diabetes drug
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Flag link:
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Ofev
SSc-ILD
Boehringer Ingelheim
FDA
Flag link:
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
Endpoints
Boehringer Ingelheim
R&D
Flag link:
Companies file suit in Canada challenging new rules to lower drug prices
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
Flag link:
MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center
MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center
BioSpace
Boehringer Ingelheim
MD Anderson Cancer Center
cancer
R&D
Flag link:
Boehringer posts solid first half as business revamp beds in
Boehringer posts solid first half as business revamp beds in
PM Live
Boehringer Ingelheim
earnings
Spiriva
Jardiance
Flag link:
Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Fierce Biotech
Boehringer Ingelheim
Bridge Biotherapeutics
Ofeva
IPF
BBT-877
Flag link:
Boehringer buys up cancer vaccine player, eyes oncology combo strategy
Boehringer buys up cancer vaccine player, eyes oncology combo strategy
Fierce Biotech
Boehringer Ingelheim
M&A
Amal Therapeutics
Flag link:
Boehringer races to catch up in NASH through Yuhan deal
Boehringer races to catch up in NASH through Yuhan deal
BioCentury
Boehringer Ingelheim
NASH
Yuhan
Flag link:
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
chronic heart failure
fast track
Flag link:
Boehringer leads investment in digital therapy for myopia
Boehringer leads investment in digital therapy for myopia
Pharmaforum
Dopavision
Boehringer Ingelheim
myopia
digital medicine
digital therapy
Flag link:
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Pharmaceutical Business Review
Boehringer Ingelheim
OSE Immuotherapeutics
clinical trials
BI 765063
solid tumors
Flag link:
Boehringer Ingelheim opens inhaler plant with 200 jobs
Boehringer Ingelheim opens inhaler plant with 200 jobs
Fierce Pharma
Boehringer Ingelheim
inhalers
drug manufacturing
Spain
Flag link:
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
ADA
diabetes
Tradjenta
Flag link:

Pages